← Leaderboards
John Wilson
Wilson Wolf Manufacturing Corporation
$12,574,861
Attributed
$14,573,536
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$14,573,536 · 10
By mechanism
R44$12,192,556 · 6
R43$1,209,373 · 3
U44$1,171,607 · 1
Top collaborators
- Adrian Philip Gee3 shared
- Mark D. Hirschel2 shared
- Sunitha Kakarla1 shared
Most similar at Wilson Wolf Manufacturing Corporation
Same institution · by research overlap
- Daniel P Welch$122,649
Others in their field
Top investigators on “Devices”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$199,696,645
- David Heimbrook · Leidos Biomedical Research, Inc.$141,696,528
- Daniel Ernest Ford · Johns Hopkins University$129,841,670
- Richard A Gibbs · Baylor College Of Medicine$118,056,644
Research focus
DevicesCell Culture TechniquesProtocols DocumentationGasesProductionConsumable /Disposable Biomedical EquipmentCellsInvestigationCommercializationDensityPositioning AttributeFeedingDoseTissue /Cell CultureProgramsIn VitroGrantPrivate SectorBiomedical Equipment DevelopmentTechnologyDesignMembraneMass Tissue /Cell CulturePreparation
Grant awards (22)
Path to Commercialization of the first âoff the shelfâ T cell product$1,022,567
R44 · FY2019 · HL · contact PI
Path to Commercialization of the first âoff the shelfâ T cell product$986,769
R44 · FY2018 · HL · contact PI
Manufacturing advances to place a powerful form of T cell therapy on the road to commercialization$923,504
R44 · FY2018 · CA · contact PI
Path to Commercialization of the first âoff the shelfâ T cell product$988,677
R44 · FY2017 · HL
Manufacturing advances to place a powerful form of T cell therapy on the road to commercialization$560,239
R44 · FY2017 · CA · contact PI
Overcoming the last barrier to commercialization of virus-specific T cell therapy$1,599,561
R44 · FY2015 · AI · contact PI
Moving TIL Therapy Past the Valley of Death$200,624
U44 · FY2014 · CA · contact PI
Moving TIL Therapy Past the Valley of Death$611,581
U44 · FY2013 · CA · contact PI
Moving TIL Therapy Past the Valley of Death$15,918
U44 · FY2012 · CA · contact PI
Moving TIL Therapy Past the Valley of Death$343,484
U44 · FY2011 · CA · contact PI
Islet culture, shipping, and infusion device$1,471,353
R44 · FY2010 · DK · contact PI
Superior cell culture device for more efficient biological production$113,520
R43 · FY2010 · GM · contact PI
Islet culture, shipping, and infusion device$1,184,237
R44 · FY2009 · DK · contact PI
Islet culture, shipping, and infusion device$1,109,370
R44 · FY2008 · DK · contact PI
Islet culture, shipping, and infusion device$510,760
R43 · FY2005 · DK
Islet culture, shipping, and infusion device$62,500
R43 · FY2005 · DK
MEMBRANE BASED ROLLER BOTTLE$695,500
R44 · FY2004 · HL
Islet culture, shipping, and infusion device$422,593
R43 · FY2004 · DK
MEMBRANE BASED ROLLER BOTTLE$591,876
R44 · FY2003 · HL
ENHANCED ROLLER BOTTLE$531,654
R44 · FY2003 · GM
ENHANCED ROLLER BOTTLE$527,249
R44 · FY2002 · GM
MEMBRANE BASED ROLLER BOTTLE$100,000
R43 · FY2000 · HL